Literature DB >> 21936637

Awareness and utilization of a prescription monitoring program among physicians.

Lance Feldman1, Kristi Skeel Williams, John Coates, Michele Knox.   

Abstract

In 2011, 5 years after the implementation of a statewide prescription monitoring program (PMP) in Ohio, a survey was distributed to physicians in five specialty areas. During the study period, 95 of 156 surveys were returned, for a 61% response rate. The purpose of the questionnaire was to assess utilization rates as well as reasons for accessing the PMP database and any influence the database may have had on prescribing practices. Over 84% of respondents were aware of the existence of the state PMP. However less than 59% of the respondents who were aware of the program had ever used it. Medical specialty was found to have a significant impact on both awareness and utilization of the system, with pediatric physicians least likely, and emergency physicians most likely, to be aware of and utilize the state PMP. Recommendations based on the authors' survey results include targeting pediatric and internal medicine providers for increased education regarding awareness and benefits of PMP utilization.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21936637     DOI: 10.3109/15360288.2011.606292

Source DB:  PubMed          Journal:  J Pain Palliat Care Pharmacother        ISSN: 1536-0288


  22 in total

1.  Prescribing practices, knowledge, and use of prescription drug monitoring programs (PDMP) by a national sample of medical toxicologists, 2012.

Authors:  Jeanmarie Perrone; Francis J DeRoos; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2012-12

2.  The effects of North Carolina's prescription drug monitoring program on the prescribing behaviors of the state's providers.

Authors:  Chris Ringwalt; Mariana Garrettson; Apostolos Alexandridis
Journal:  J Prim Prev       Date:  2015-04

Review 3.  Windmills and pill mills: can PDMPs tilt the prescription drug epidemic?

Authors:  Hallam Gugelmann; Jeanmarie Perrone; Lewis Nelson
Journal:  J Med Toxicol       Date:  2012-12

4.  Does Prescription Opioid Shopping Increase Overdose Rates in Medicaid Beneficiaries?

Authors:  Benjamin C Sun; Nicoleta Lupulescu-Mann; Christina J Charlesworth; Hyunjee Kim; Daniel M Hartung; Richard A Deyo; K John McConnell
Journal:  Ann Emerg Med       Date:  2017-11-24       Impact factor: 5.721

5.  How, why, and for whom do emergency medicine providers use prescription drug monitoring programs?

Authors:  Robert J Smith; Austin S Kilaru; Jeanmarie Perrone; Breah Paciotti; Frances K Barg; Sarah M Gadsden; Zachary F Meisel
Journal:  Pain Med       Date:  2015-02-17       Impact factor: 3.750

Review 6.  Provider perceptions of system-level opioid prescribing and addiction treatment policies.

Authors:  Rebecca L Haffajee; Cecelia A French
Journal:  Curr Opin Psychol       Date:  2019-02-04

7.  Mandatory Provider Review And Pain Clinic Laws Reduce The Amounts Of Opioids Prescribed And Overdose Death Rates.

Authors:  Deborah Dowell; Kun Zhang; Rita K Noonan; Jason M Hockenberry
Journal:  Health Aff (Millwood)       Date:  2016-10-01       Impact factor: 6.301

8.  Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians.

Authors:  Jessica M Irvine; Sara E Hallvik; Christi Hildebran; Miguel Marino; Todd Beran; Richard A Deyo
Journal:  J Pain       Date:  2014-04-29       Impact factor: 5.820

9.  Development and Feasibility of an Academic Detailing Intervention to Improve Prescription Drug Monitoring Program Use Among Physicians.

Authors:  Kelly S Barth; Sarah Ball; Rachel S Adams; Ruslan Nikitin; Nikki R Wooten; Zaina P Qureshi; Mary J Larson
Journal:  J Contin Educ Health Prof       Date:  2017       Impact factor: 1.355

10.  Opioid prescribing and risk of drug-opioid interactions in older discharged patients with polypharmacy in Australia.

Authors:  Aymen Ali Al-Qurain; Lemlem G Gebremichael; Mohammed S Khan; Desmond B Williams; Lorraine Mackenzie; Craig Phillips; Patrick Russell; Michael S Roberts; Michael D Wiese
Journal:  Int J Clin Pharm       Date:  2020-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.